836
Views
6
CrossRef citations to date
0
Altmetric
Research Paper

A feasibility study on gene therapy of pancreatic carcinoma with Ad-PUMA

, , , , , , , , , , , , & show all
Pages 712-719 | Received 10 Oct 2011, Accepted 29 Apr 2012, Published online: 23 May 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Justin W Ady, Jacqueline Heffner, Elizabeth Klein & Yuman Fong. (2014) Oncolytic viral therapy for pancreatic cancer: current research and future directions. Oncolytic Virotherapy 3, pages 35-46.
Read now

Articles from other publishers (5)

Naureen Ali & Nimisha Srivastava. (2021) Recent Advancements for the Management of Pancreatic Cancer: Current Insights. Current Cancer Therapy Reviews 17:4, pages 267-282.
Crossref
Ket Hing Chong, Sandhya Samarasinghe, Don Kulasiri & Jie Zheng. (2019) Mathematical modelling of core regulatory mechanism in p53 protein that activates apoptotic switch. Journal of Theoretical Biology 462, pages 134-147.
Crossref
Chun-Ju Liu, Xia-Li Zhang, Da-Ya Luo, Wei-Feng Zhu, Hui-Fang Wan, Jun-Ping Yang, Xiao-Jun Yang & Fu-Sheng Wan. (2015) Exogenous p53 Upregulated Modulator of Apoptosis (PUMA) Decreases Growth of Lung Cancer A549 Cells. Asian Pacific Journal of Cancer Prevention 16:2, pages 741-746.
Crossref
YAN ZHANG, HUI-YAN LUO, GUANG-LIN LIU, DE-SHEN WANG, ZHI-QIANG WANG, ZHAO-LEI ZENG & RUI-HUA XU. (2015) Prognostic significance and therapeutic implications of peroxisome proliferator-activated receptor γ overexpression in human pancreatic carcinoma. International Journal of Oncology 46:1, pages 175-184.
Crossref
Fei Liao, Meng-Yao Ji, Lei Shen, Shi Qiu, Xu-feng Guo & Wei-guo Dong. (2013) Decreased EGR3 expression is related to poor prognosis in patients with gastric cancer. Journal of Molecular Histology 44:4, pages 463-468.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.